Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene [3]

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 798-799

  Mendes, Rodrigo E ^a   Bell, Jan M ^b   Turnidge, John D ^b   Yang, Qiwen ^c   Yu, Nsong ^d   Sun, Ziyong ^e   Jones, Ronald N ^a  

^a JMI LABORATORIES   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d Zhejiang Medical Centre #1 Hospital   (China)

^e Tongji Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MEZLOCILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULBACTAM; SULPERAZON; TEICOPLANIN; TIGECYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; BLA IMP4 GENE; BLA KPC2 GENE; CASE REPORT; CHINA; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME ISOLATION; ESCHERICHIA COLI K 12; FEMALE; GENE; HUMAN; INFANT; ISOLATION PROCEDURE; KLEBSIELLA PNEUMONIAE; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; QNRB4 GENE;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHINA; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI K12; FEMALE; FLUOROQUINOLONES; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 38649126211     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01185-07     Document Type: Letter

References (15)

1. Bert, F., D. Vanjak, V. Leflon-Guibout, S. Mrejen, S. Delpierre, A. Redondo, and M. H. Nicolas-Chanoine. 2007. IMP-4-producing Pseudomonas aeruginosa in a French patient repatriated from Malaysia: impact of early detection and control measures. Clin. Infect. Dis. 44:764-765.
2. Bradford, P. A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, and J. Quale. 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis. 39:55-60.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A7, 7th ed. CLSI, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; M100-S17, 17th informational supplement. CLSI, Wayne, PA.
5. Deshpande, L. M., R. N. Jones, T. R. Fritsche, and H. S. Sader. 2006. Occurrence and characterization of carbapenemases produced by Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb. Drug Resist. 12:223-230.
6. Mendes, R. E., K. A. Kiyota, J. Monteiro, M. Castanheira, S. S. Andrade, A. C. Gales, A. C. Pignatari, and S. Tufik. 2007. Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45:544-547.
7. IMP-16, and a fused form of aminoglycoside-resistant gene aac(6′)-30/aac(6′)-Ib′: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:4693-4702.
8. Navon-Venezia, S., I. Chmelnitsky, A. Leavitt, M. J. Schwaber, D. Schwartz, and Y. Carmeli. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.
9. Rossolini, G. M. 2005. Acquired metallo-β-lactamases: an increasing clinical threat. Clin. Infect. Dis. 41:1557-1558.
10. Villegas, M. V., K. Lilians, A. Correa, J. N. Kattan, J. A. Lopez, and J. P. Quinn. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553-1555.
11. Villegas, M. V., K. Lilians, A. Correa, C. J. Suarez, J. A. Lopez, M. Vallejo, and J. P. Quinn. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.
12. Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
13. Wei, Z. Q., X. X. Du, Y. S. Yu, P. Shen, Y. G. Chen, and L. J. Li. 2007. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob. Agents Chemother. 51:763-765.
14. Wu, J. J., W. C. Ko, S. H. Tsai, and J. J. Yan. 2007. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 51:1223-1227.
15. Zhang, R., H. W. Zhou, J. C. Cai, and G. X. Chen. 2007. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J. Antimicrob. Chemother. 59:574-576.